United States
# |
Name |
EBITDA Margin |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
---|---|---|---|---|---|---|---|
1 |
44.11%
|
Sept. 30, 2024 | USD 3.15 | 2.27% |
|
United States |
|
2 |
40.50%
|
June 30, 2024 | USD 3.41 | -1.44% |
|
United States |
|
3 |
33.65%
|
Sept. 29, 2024 | USD 151.87 | -0.18% |
|
United States |
|
4 |
33.62%
|
Dec. 31, 2024 | USD 240.55 | 1.85% |
|
United States |
|
5 |
33.04%
|
Sept. 30, 2024 | USD 108.16 | -1.21% |
|
United States |
|
6 |
32.52%
|
Sept. 30, 2024 | USD 13.71 | NA |
|
United States |
|
7 |
31.83%
|
Sept. 30, 2024 | USD 75.32 | -1.89% |
|
United States |
|
8 |
30.33%
|
Oct. 5, 2024 | USD 6.70 | -0.74% |
|
United States |
|
9 |
30.04%
|
Sept. 30, 2024 | USD 16.36 | -1.86% |
|
United States |
|
10 |
30.00%
|
Sept. 30, 2024 | USD 8.11 | -1.58% |
|
United States |
|
11 |
26.77%
|
Sept. 30, 2024 | USD 3.05 | -5.57% |
|
United States |
|
12 |
26.32%
|
Sept. 30, 2024 | USD 14.91 | -4.18% |
|
United States |
|
13 |
25.95%
|
Oct. 31, 2024 | USD 95.34 | -1.25% |
|
United States |
|
14 |
25.33%
|
Dec. 31, 2024 | USD 150.04 | -1.42% |
|
United States |
|
15 |
25.21%
|
Sept. 30, 2024 | USD 15.53 | -1.40% |
|
United States |
|
16 |
24.75%
|
Dec. 31, 2024 | USD 405.10 | 2.38% |
|
United States |
|
17 |
21.67%
|
Sept. 30, 2024 | USD 74.06 | -1.65% |
|
United States |
|
18 |
21.26%
|
Sept. 29, 2024 | USD 21.23 | -0.28% |
|
United States |
|
19 |
20.51%
|
Sept. 30, 2024 | USD 144.64 | 2.66% |
|
United States |
|
20 |
20.49%
|
Sept. 30, 2024 | USD 215.82 | -1.50% |
|
United States |
|
21 |
19.76%
|
Sept. 30, 2024 | USD 8.05 | -1.71% |
|
United States |
|
22 |
15.87%
|
Sept. 30, 2024 | USD 4.92 | 2.71% |
|
United States |
|
23 |
15.78%
|
Sept. 30, 2024 | USD 33.88 | -1.51% |
|
United States |
|
24 |
12.95%
|
Sept. 28, 2024 | USD 31.64 | -2.85% |
|
United States |
|
25 |
12.35%
|
Sept. 30, 2024 | USD 20.18 | 2.59% |
|
United States |
|
26 |
10.95%
|
Sept. 30, 2024 | USD 75.79 | 0.66% |
|
United States |
|
27 |
10.39%
|
Sept. 30, 2024 | USD 88.15 | -0.63% |
|
United States |
|
28 |
9.88%
|
Sept. 30, 2024 | USD 10.24 | -5.36% |
|
United States |
|
29 |
9.57%
|
Sept. 30, 2024 | USD 13.74 | -0.72% |
|
United States |
|
30 |
8.92%
|
Sept. 30, 2024 | USD 142.42 | 1.98% |
|
United States |
|
31 |
8.54%
|
Sept. 30, 2024 | USD 92.15 | -0.38% |
|
United States |
|
32 |
6.82%
|
Sept. 28, 2024 | USD 79.57 | -0.54% |
|
United States |
|
33 |
6.28%
|
Sept. 30, 2024 | USD 1.66 | -0.60% |
|
United States |
|
34 |
6.20%
|
Sept. 30, 2024 | USD 16.14 | -1.10% |
|
United States |
|
35 |
6.09%
|
Sept. 28, 2024 | USD 4.62 | 0.43% |
|
United States |
|
36 |
5.99%
|
Sept. 30, 2024 | USD 11.39 | 3.08% |
|
United States |
|
37 |
5.98%
|
Dec. 31, 2024 | USD 548.18 | 1.05% |
|
United States |
|
38 |
5.93%
|
Sept. 30, 2024 | USD 23.60 | 1.86% |
|
United States |
|
39 |
5.82%
|
Sept. 28, 2024 | USD 10.50 | -1.69% |
|
United States |
|
40 |
5.22%
|
Oct. 26, 2024 | USD 30.98 | 0.10% |
|
United States |
|
41 |
4.66%
|
Sept. 30, 2024 | USD 325.36 | 4.82% |
|
United States |
|
42 |
4.56%
|
Sept. 30, 2024 | USD 38.93 | 4.43% |
|
United States |
|
43 |
4.04%
|
Sept. 30, 2024 | USD 292.46 | -0.60% |
|
United States |
|
44 |
3.85%
|
Sept. 30, 2024 | USD 23.60 | -2.64% |
|
United States |
|
45 |
3.64%
|
Sept. 30, 2024 | USD 64.82 | 1.23% |
|
United States |
|
46 |
3.27%
|
Sept. 30, 2024 | USD 293.00 | -0.08% |
|
United States |
|
47 |
3.22%
|
Sept. 30, 2024 | USD 191.94 | -0.81% |
|
United States |
|
48 |
2.64%
|
Sept. 30, 2024 | USD 10.21 | -2.30% |
|
United States |
|
49 |
2.58%
|
Sept. 30, 2024 | USD 16.26 | -0.24% |
|
United States |
|
50 |
2.00%
|
Sept. 30, 2024 | USD 19.35 | -2.08% |
|
United States |
The Dental Care company in United States with the highest EBITDA Margin is American Shared Hospital Services (NYSE American: AMS) at 44.11%.
The Dental Care company in United States with the lowest EBITDA Margin is Palisade Bio, Inc. (NasdaqCM: PALI) at -5,182.00%.
The top 10 Dental Care companies in United States by EBITDA Margin are American Shared Hospital Services, Waldencast plc, Johnson & Johnson, ResMed Inc., Zimmer Biomet Holdings, Inc., Sotera Health Company, Prestige Consumer Healthcare Inc., European Wax Center, Inc., National Research Corporation and Sensus Healthcare, Inc..
The bottom 10 Dental Care companies in United States by EBITDA Margin are Palisade Bio, Inc., Vivos Therapeutics, Inc., Inspire Veterinary Partners, Inc., PROCEPT BioRobotics Corporation, Envista Holdings Corp, Cannae Holdings, Inc., Treace Medical Concepts, Inc., Journey Medical Corporation, OPKO Health, Inc. and Anika Therapeutics, Inc..